§ BIOTECHNOLOGY
USD · BiotechnologyAGIO
AGIOS PHARMACEUTICALS INC
USDSector · BiotechnologyBeta · 0.60
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
137 increased/new, 71 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 1.33 | EPS (TTM) | -7.25 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| BlackRock, Inc. | 5.8M | 0.0% | +10% |
| State Street | 3.4M | 0.0% | +8% |
| ARMISTICE CAPITAL, LLC | 2.7M | 1.6% | −11% |
| DE Shaw | 2.7M | 0.1% | +46% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.6M | n/a | n/a |
| Lynx1 Capital Management LP | 2.6M | 14.0% | +3180% |
◇ AC INTELLIGENCE
Top institutional owners for AGIO as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER96.0% · 0 holders
OTHER2.6% · 160 holders
PASSIVE / INDEX0.5% · 8 holders
DEALER / BANK0.4% · 22 holders
QUALITY / COMPOUNDER0.2% · 17 holders
ACTIVIST0.2% · 1 holder
SYSTEMATIC / QUANT0.1% · 8 holders
TACTICAL / MACRO0.1% · 5 holders
INCOME / DEFENSIVE0.0% · 13 holders
GROWTH / MOMENTUM0.0% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for AGIO in the last 180 days.